Live Updates: COVID-19 Cases
  • World 19,786,635
    World
    Confirmed: 19,786,635
    Active: 6,351,109
    Recovered: 12,706,945
    Death: 728,581
  • USA 5,149,229
    USA
    Confirmed: 5,149,229
    Active: 2,345,860
    Recovered: 2,638,303
    Death: 165,066
  • Brazil 3,013,369
    Brazil
    Confirmed: 3,013,369
    Active: 818,533
    Recovered: 2,094,293
    Death: 100,543
  • India 2,152,020
    India
    Confirmed: 2,152,020
    Active: 628,763
    Recovered: 1,479,804
    Death: 43,453
  • Russia 882,347
    Russia
    Confirmed: 882,347
    Active: 177,286
    Recovered: 690,207
    Death: 14,854
  • South Africa 553,188
    South Africa
    Confirmed: 553,188
    Active: 138,410
    Recovered: 404,568
    Death: 10,210
  • Peru 471,012
    Peru
    Confirmed: 471,012
    Active: 130,997
    Recovered: 319,171
    Death: 20,844
  • Mexico 469,407
    Mexico
    Confirmed: 469,407
    Active: 104,710
    Recovered: 313,386
    Death: 51,311
  • Chile 371,023
    Chile
    Confirmed: 371,023
    Active: 16,879
    Recovered: 344,133
    Death: 10,011
  • Spain 361,442
    Spain
    Confirmed: 361,442
    Active: 332,939
    Recovered: ?
    Death: 28,503
  • Iran 324,692
    Iran
    Confirmed: 324,692
    Active: 24,306
    Recovered: 282,122
    Death: 18,264
  • UK 309,763
    UK
    Confirmed: 309,763
    Active: 263,197
    Recovered: ?
    Death: 46,566
  • Saudi Arabia 287,262
    Saudi Arabia
    Confirmed: 287,262
    Active: 33,692
    Recovered: 250,440
    Death: 3,130
  • Pakistan 283,487
    Pakistan
    Confirmed: 283,487
    Active: 17,815
    Recovered: 259,604
    Death: 6,068
  • Bangladesh 255,113
    Bangladesh
    Confirmed: 255,113
    Active: 105,144
    Recovered: 146,604
    Death: 3,365
  • Italy 250,103
    Italy
    Confirmed: 250,103
    Active: 12,953
    Recovered: 201,947
    Death: 35,203
  • Turkey 239,622
    Turkey
    Confirmed: 239,622
    Active: 11,137
    Recovered: 222,656
    Death: 5,829
  • Germany 216,896
    Germany
    Confirmed: 216,896
    Active: 10,235
    Recovered: 197,400
    Death: 9,261
  • France 197,921
    France
    Confirmed: 197,921
    Active: 84,761
    Recovered: 82,836
    Death: 30,324
  • Canada 119,221
    Canada
    Confirmed: 119,221
    Active: 6,679
    Recovered: 103,566
    Death: 8,976
  • China 84,596
    China
    Confirmed: 84,596
    Active: 839
    Recovered: 79,123
    Death: 4,634
  • Netherlands 57,987
    Netherlands
    Confirmed: 57,987
    Active: 51,830
    Recovered: ?
    Death: 6,157
  • Australia 20,698
    Australia
    Confirmed: 20,698
    Active: 9,100
    Recovered: 11,320
    Death: 278
  • S. Korea 14,562
    S. Korea
    Confirmed: 14,562
    Active: 629
    Recovered: 13,629
    Death: 304
  • New Zealand 1,569
    New Zealand
    Confirmed: 1,569
    Active: 23
    Recovered: 1,524
    Death: 22

IBM’s machine learning tech could predict Alzheimer’s risk in individuals

Author at TechGenyz Science
Alzheimer Disease Predicted By Machine Learning

Brain Awareness Week, which occurs every March, is a global campaign to increase public awareness of the progress and benefits of brain research. And today, a research paper has been published that discusses how a set of proteins in the blood might possibly give an indication of later-to-come Alzheimer’s disease in an individual.

In a research conducted by Ben Goudey, a researcher at the Genomics Research Team of IBM Research, and his team at IBM Research- Australia it is found that machine learning has been utilized to identify a set of proteins in the blood that can predict the concentration of the biomarker amyloid-beta (amyloid-β) in spinal fluid, which can help predict the risk of Alzheimer’s disease long before it gets detected, because Alzheimer’s usually gets detected in the later stages.

The peptide known as amyloid-beta has been proven to change prior to visible memory-related issues, and examination of the concentration of the amyloid-beta in the spinal fluid can provide an indication of the risk of Alzheimer’s disease years before it can occur. However, accessing spinal fluid is highly invasive and expensive.

Goudey’s latest research has potentially identified proteins in the bloodstream that might indicate the concentration of amyloid-β in the spinal fluid. Thus, less invasive tests such as a blood test can be conducted instead of people having to go through the more invasive spinal fluid test.

This research, when it comes into fruition, can help the field of medicine take one step forward to the potential of detecting Alzheimer’s disease at a budding stage through machine learning, AI and technology.

The research paper by Goudey and his team, dated March 11, 2019, has been published in the Scientific Reports. The research, which is still in its initial stages, might help clinicians to predict the risks with an accuracy of up to 77 percent.

Goudey also hopes that the research would improve the selection of people for drug trials, as

Individuals with mild cognitive impairment who were predicted to have an abnormal concentration of amyloid in their spinal fluid were found to be 2.5 times more likely to develop Alzheimer’s disease

Moreover, Goudey and his team have also been working on a blood test for another important biomarker of Alzheimer’s disease, which is known as tau, which they are going to present at the end of this month at the 14th International Conference on Alzheimer’s and Parkinson’s Diseases in Lisbon.

Career

Subscribe